Scarica l'app Stockscreener
7.94
12.94%
0.91
Dopo l'orario di chiusura:
7.94
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ETNB Giù?
Forum
Previsione
Precedente Chiudi:
$7.03
Aprire:
$7.03
Volume 24 ore:
4.34M
Relative Volume:
4.79
Capitalizzazione di mercato:
$933.60M
Reddito:
-
Utile/perdita netta:
$-174.61M
Rapporto P/E:
-3.763
EPS:
-2.11
Flusso di cassa netto:
$-165.54M
1 W Prestazione:
+3.25%
1M Prestazione:
-0.50%
6M Prestazione:
+0.13%
1 anno Prestazione:
-22.39%
Intervallo 1D:
$6.60
$7.95
Intervallo di 1 settimana:
$6.43
$8.09
Portata 52W:
$6.43
$16.63
89 Bio Inc Stock (ETNB) Company Profile
Nome
89 Bio Inc
Settore
Industria
Telefono
(415) 432-9270
Indirizzo
142 SANSOME STREET, SAN FRANCISCO, CA
Confronta ETNB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
7.94 | 933.60M | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-22 | Ripresa | BofA Securities | Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2023-08-28 | Iniziato | UBS | Buy |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2022-05-12 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-26 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Ripresa | BTIG Research | Buy |
| 2021-05-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-19 | Iniziato | Raymond James | Strong Buy |
| 2020-09-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-31 | Iniziato | Piper Sandler | Overweight |
| 2020-07-23 | Iniziato | BTIG Research | Buy |
| 2020-07-07 | Iniziato | Chardan Capital Markets | Buy |
| 2019-12-09 | Iniziato | BofA/Merrill | Neutral |
| 2019-12-09 | Iniziato | Oppenheimer | Outperform |
| 2019-12-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-12-09 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
89 Bio Inc Borsa (ETNB) Ultime notizie
89bio (NASDAQ:ETNB) Sets New 1-Year LowWhat's Next? - MarketBeat
89bio stock hits 52-week low at $6.96 amid market challenges - Investing.com Canada
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
89bio Grants Inducement Stock Options to New Employee Under 2023 Plan - StockTitan
89bio (NASDAQ:ETNB) Shares Down 4.5%Here's What Happened - MarketBeat
Wellington Management Group LLP Reduces Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Fmr LLC Purchases 70,129 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
89bio stock hits 52-week low at $6.96 amid market challenges By Investing.com - Investing.com South Africa
Short Interest in 89bio, Inc. (NASDAQ:ETNB) Increases By 6.5% - MarketBeat
89Bio's SWOT analysis: pegozafermin's potential in MASH treatment stock By Investing.com - Investing.com Canada
89Bio's SWOT analysis: pegozafermin's potential in MASH treatment stock - Investing.com India
89bio issues retention RSUs to top executives By Investing.com - Investing.com South Africa
89bio issues retention RSUs to top executives - Investing.com
89bio Strengthens Leadership Retention with New RSUs - TipRanks
89bio : Management Change/Compensation Form 8 K - Marketscreener.com
89bio (NASDAQ:ETNB) Upgraded at Raymond James - Defense World
89bio (NASDAQ:ETNB) Shares Down 5%Here's What Happened - MarketBeat
89bio (NASDAQ:ETNB) Stock Rating Upgraded by Raymond James - MarketBeat
Charles Schwab Investment Management Inc. Purchases 53,932 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio CEO Rohan Palekar buys $39,450 in company stock By Investing.com - Investing.com Australia
Insider Buying: 89bio, Inc. (NASDAQ:ETNB) CEO Acquires 5,000 Shares of Stock - MarketBeat
CEO Rohan Palekar Increases Stake in 89bio Inc (ETNB) with Recen - GuruFocus.com
89bio CEO Rohan Palekar buys $39,450 in company stock - Investing.com
Analysts Set 89bio, Inc. (NASDAQ:ETNB) PT at $30.33 - Defense World
89bio, Inc. (NASDAQ:ETNB) Director Charles Mcwherter Purchases 10,000 Shares - MarketBeat
Insider Buying: Charles Mcwherter Acquires Shares of 89bio Inc (ETNB) - GuruFocus.com
89bio director Charles McWherter purchases $80,000 in stock By Investing.com - Investing.com Nigeria
89bio director Charles McWherter purchases $80,000 in stock - Investing.com
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by Jacobs Levy Equity Management Inc. - MarketBeat
89bio (NASDAQ:ETNB) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Analysts Set 89bio, Inc. (NASDAQ:ETNB) Target Price at $30.33 - MarketBeat
89Bio's SWOT analysis: pegoza's potential in MASH treatment faces market hurdles - Investing.com Nigeria
Redmile Group LLC Sells 175,806 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
Janus Henderson Group PLC Purchases 1,882,108 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
Canterra Minerals announces private placement for proceeds of up to C$3M - MSN
Why Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Insider Monkey
ICICI Bank Ltd. ADR (NYSE: IBN) Up 27.89% This Year: What Is Going To Happen Next - Stocks Register
10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds - Insider Monkey
eHealth initiated with a Neutral at UBS - MSN
HighVista Strategies LLC Acquires New Shares in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
LMS Compliance Boosts ESG Standards for Malaysian SMEs - MSN
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by Walleye Capital LLC - MarketBeat
Erste Asset Management GmbH Acquires New Position in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
Stock market today: Senti Biosciences +412.04%, NovoCure +31.89% among top gainers in early trading - Business Upturn
BPGbio reports data on brain-penetrant microtubule destabilizing agent BRG-399 - BioWorld Online
PDT Partners LLC Buys New Shares in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat
89bio Grants Stock Options to New Employees in Key Retention Move | ETNB Stock News - StockTitan
89 Bio Inc Azioni (ETNB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
89 Bio Inc Azioni (ETNB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McWherter Charles | Director |
Dec 05 '24 |
Buy |
8.00 |
10,000 |
80,000 |
10,000 |
| PALEKAR ROHAN | Chief Executive Officer |
Nov 22 '24 |
Buy |
8.35 |
10,000 |
83,500 |
466,236 |
| Le-Nguyen Quoc | See Remarks |
Oct 30 '24 |
Sale |
8.12 |
27,955 |
226,995 |
187,796 |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):